Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Suspended 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2

Conditions

Neurofibromatosis 1 2Port-Wine Stain 1Neurofibromatoses 1Hemangioma, Capillary 1

Interventions

pembrolizumab 603Cyclophosphamide 545Magnetic Resonance Spectroscopy 527Radiotherapy 513Specimen Handling 505Nivolumab 411Cisplatin 381Carboplatin 369Biopsy 305Blood Specimen Collection 304Radiosurgery 290Paclitaxel 281Gemcitabine 271Surveys and Questionnaires 269Standard of Care 267fludarabine 263Drug Therapy 263Dexamethasone 263Bevacizumab 252venetoclax 251Oxaliplatin 209Capecitabine 199Rituximab 198Radiation 191Ipilimumab 188Fluorouracil 188durvalumab 185Doxorubicin 178Etoposide 177atezolizumab 172

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Lasers, Solid-State × 1 year × Clear all
NCT06934928 2026-06-04

Assessing the Efficacy of Repeat, Monthly Treatments of Alexandrite Laser for NF1-associated Cutaneous Neurofibromas (cNFs)

Massachusetts General Hospital

Phase NA Suspended
10 enrolled
CNS

Neurofibromatosis 1, Neurofibromatoses

NCT06132165 2025-11-21

Efficacy of Skin Cooling in Reducing Pain Associated With Non-invasive Treatments of Neurofibromatosis Type 1 Cutaneous Neurofibromas

Massachusetts General Hospital

Phase 1 Completed
13 enrolled
CNS

Neurofibromatosis 1

NCT07183644 2025-09-19

Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients

University of Texas Southwestern Medical Center

Phase NA Not yet recruiting
200 enrolled

Hemangioma, Capillary, Port-Wine Stain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡